Midgard Science

Labs / CDMO: development & manufacturing

V

Viralgen

San Sebastián, Spain · viralgen.com

GMP

On your own

Free. Their own form.

Contact Viralgen directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Viralgen is an AAV-based gene therapy CDMO that provides end-to-end manufacturing support from construct optimization and plasmid DNA production through clinical and commercial production. It serves biotech and pharmaceutical clients developing gene therapies for rare, ultra-rare, and other genetic diseases from its facilities in San Sebastián, Spain.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Process development

    Supports early-stage programs with platform fit, construct optimization, and production strategy, and supports late-stage programs with comparability studies, next-generation process transition, and process characterization/PPQ.

  • AAV manufacturing platform

    Uses the Aava™ platform and Pro10™ cell line to manufacture AAV gene therapies with a high-yield, scalable process.

  • Early phase production

    Produces material for development, toxicology, and Phase I clinical needs from small screening batches through cGMP batches.

  • Late phase production

    Provides manufacturing support for late-stage clinical development and commercialization, including process characterization and PPQ planning.

  • Commercial production

    Provides large-scale AAV manufacturing for commercial supply, including scale-up and scale-out to meet demand.

  • Fill and finish

    Performs fill and finish in dedicated suites with automated isolator-based operations.

  • QC release

    Carries out quality control release work, with much of the QC and CMC work performed in-house.

  • MSAT services

    Supports manufacturing science and technology activities, including process characterization and scale-down studies.

  • Plasmid DNA production

    Provides plasmid DNA production as part of the AAV manufacturing workflow.

What they work on

Modalities
Viral vector, Cell therapy, Plasmid DNA
Species and models
HEK293-derived cell line, Pro10™ suspension cell line
Assays and studies
ELISA, DNA analysis, physicochemical testing, analytical characterization, process characterization
Instruments and platforms
Ambr250 HT system, ultracentrifugation, depth filtration, chromatography skids, tangential flow filtration
Scale and capacity
2L screening batches, 50L toxicology batches, 250L-500L cGMP batches, up to 1,500L per batch, up to 2,000L single-use bioreactors per suite, 3 modules, up to 3 production trains per module, 343,000+ square feet, 45,000 square feet of clinical-stage infrastructure, 300,000+ square feet of commercial readiness, 1000m2 MSAT cGMP-like laboratory
Therapeutic areas
gene therapy, rare diseases, ultra-rare diseases, pathway diseases, drug-resistant focal epilepsy, Spastic Paraplegia 50, Charcot-Marie-Tooth disease type 4J, AADC deficiency, NPC, NPA, Duchenne muscular dystrophy exon 1 deletion, MPS IIIC
Type
CDMO
Sites
San Sebastián, Spain
Team
400+ professionals
Quality
cGMP certification by AEMPS (manufacture of human medicinal products, investigational medicinal products and sterile or biological active substances) · EMA cGMP certified through Phase 3 (clinical operations and commercial readiness) · 100% success rate on IND/IMPD dossier su
Founded
2017

Similar labs. AGC Biologics, Esco Aster, eXmoor Pharma, Minaris

Found in a contract services directory. Listing built from viralgen.com. Work here? Claim this listing.

Viralgen · Midgard Science